Kristiaan Lenos

1.2k total citations
27 papers, 517 citations indexed

About

Kristiaan Lenos is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Kristiaan Lenos has authored 27 papers receiving a total of 517 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 14 papers in Molecular Biology and 12 papers in Cancer Research. Recurrent topics in Kristiaan Lenos's work include Cancer Genomics and Diagnostics (11 papers), Genetic factors in colorectal cancer (6 papers) and Cancer Cells and Metastasis (6 papers). Kristiaan Lenos is often cited by papers focused on Cancer Genomics and Diagnostics (11 papers), Genetic factors in colorectal cancer (6 papers) and Cancer Cells and Metastasis (6 papers). Kristiaan Lenos collaborates with scholars based in Netherlands, United Kingdom and United States. Kristiaan Lenos's co-authors include Aart G. Jochemsen, Louis Vermeulen, Sandra J. van Vliet, Lisanne E. Nijman, Kirsten Lodder, Amina F.A.S. Teunisse, Daniël M. Miedema, Ilona M. Vuist, Frank Bartel and Maria C. Lecca and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Kristiaan Lenos

25 papers receiving 511 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kristiaan Lenos Netherlands 14 342 237 169 75 47 27 517
Fumihiko Kakizaki Japan 9 322 0.9× 215 0.9× 137 0.8× 71 0.9× 35 0.7× 17 517
Natascha Cremers Germany 11 239 0.7× 290 1.2× 137 0.8× 92 1.2× 68 1.4× 12 516
Andrea Bisso Italy 10 518 1.5× 291 1.2× 159 0.9× 54 0.7× 78 1.7× 17 692
Martin C. Whittle United States 9 331 1.0× 325 1.4× 141 0.8× 65 0.9× 42 0.9× 11 558
Brunella Costanza Belgium 8 279 0.8× 197 0.8× 156 0.9× 67 0.9× 63 1.3× 9 470
Lorena Alonso‐Alconada Spain 12 247 0.7× 223 0.9× 216 1.3× 55 0.7× 46 1.0× 20 478
Marie P. Khoury United Kingdom 8 535 1.6× 433 1.8× 175 1.0× 45 0.6× 34 0.7× 10 774
Nikia A. Laurie United States 10 455 1.3× 485 2.0× 131 0.8× 65 0.9× 38 0.8× 12 756
Federica Guffanti Italy 13 374 1.1× 300 1.3× 143 0.8× 37 0.5× 48 1.0× 33 577
Roza Zandi Denmark 7 324 0.9× 264 1.1× 103 0.6× 37 0.5× 50 1.1× 9 540

Countries citing papers authored by Kristiaan Lenos

Since Specialization
Citations

This map shows the geographic impact of Kristiaan Lenos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kristiaan Lenos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kristiaan Lenos more than expected).

Fields of papers citing papers by Kristiaan Lenos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kristiaan Lenos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kristiaan Lenos. The network helps show where Kristiaan Lenos may publish in the future.

Co-authorship network of co-authors of Kristiaan Lenos

This figure shows the co-authorship network connecting the top 25 collaborators of Kristiaan Lenos. A scholar is included among the top collaborators of Kristiaan Lenos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kristiaan Lenos. Kristiaan Lenos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Harryvan, Tom J., Kristiaan Lenos, Tamsin R.M. Lannagan, et al.. (2025). TGFβ signaling in cancer-associated fibroblasts drives a hepatic gp130-dependent pro-metastatic inflammatory program in colorectal cancer. iScience. 28(11). 113696–113696.
2.
Back, Tim R. de, Tan Wu, Sanne ten Hoorn, et al.. (2024). A consensus molecular subtypes classification strategy for clinical colorectal cancer tissues. Life Science Alliance. 7(8). e202402730–e202402730. 4 indexed citations
3.
Verhoeff, Jan, Jurriaan B. Tuynman, Manon E. Wildenberg, et al.. (2024). T-cell responses in colorectal peritoneal metastases are recapitulated in a humanized immune system mouse model. Frontiers in Immunology. 15. 1415457–1415457. 1 indexed citations
4.
Buikhuisen, Joyce Y., Kate Cameron, Saskia J.E. Suijkerbuijk, et al.. (2023). Subtype-specific kinase dependency regulates growth and metastasis of poor-prognosis mesenchymal colorectal cancer. Journal of Experimental & Clinical Cancer Research. 42(1). 56–56. 4 indexed citations
5.
Hoebe, Ron A., Kristiaan Lenos, Sander J. Tans, et al.. (2023). Using picoliter droplet deposition to track clonal competition in adherent and organoid cancer cell cultures. Scientific Reports. 13(1). 18832–18832.
6.
Pol, Ymke van der, Anouk E. Hentschel, Jip Ramaker, et al.. (2023). Real‐time analysis of the cancer genome and fragmentome from plasma and urine cell‐free DNA using nanopore sequencing. EMBO Molecular Medicine. 15(12). e17282–e17282. 29 indexed citations
7.
Moldován, Norbert, Ymke van der Pol, Tom van den Ende, et al.. (2023). Multi-modal cell-free DNA genomic and fragmentomic patterns enhance cancer survival and recurrence analysis. Cell Reports Medicine. 5(1). 101349–101349. 26 indexed citations
8.
Jongerius, Chiara, Louis Vermeulen, Marjolein van Egmond, et al.. (2022). Behavioral factors to modulate immunotherapy efficacy in cancer. Frontiers in Immunology. 13. 1066359–1066359. 3 indexed citations
9.
Westendorp, B. Florien, Philip W. Voorneveld, Pim J. Koelink, et al.. (2022). Loss of bone morphogenetic protein signaling in fibroblasts results in CXCL12-driven serrated polyp development. Journal of Gastroenterology. 58(1). 25–43. 4 indexed citations
10.
Bosch, Tom van den, Lisanne E. Nijman, Leandro F. Moreno, et al.. (2021). Continuous clonal labeling reveals uniform progenitor potential in the adult exocrine pancreas. Cell stem cell. 28(11). 2009–2019.e4. 10 indexed citations
11.
Bastiaenen, Vivian P., Charlotte E.L. Klaver, Lisanne E. Nijman, et al.. (2020). A mouse model for peritoneal metastases of colorectal origin recapitulates patient heterogeneity. Laboratory Investigation. 100(11). 1465–1474. 23 indexed citations
12.
Bosch, Tom van den, Lisanne E. Nijman, Sanne M. van Neerven, et al.. (2020). Continuous Clonal Labeling Reveals Uniform Progenitor Potential in the Adult Exocrine Pancreas. SSRN Electronic Journal. 1 indexed citations
13.
Lenos, Kristiaan, et al.. (2019). A marker-independent lineage-tracing system to quantify clonal dynamics and stem cell functionality in cancer tissue. Nature Protocols. 14(9). 2648–2671. 4 indexed citations
14.
Lenos, Kristiaan, Jeroen Goos, Ilona M. Vuist, et al.. (2015). MGL ligand expression is correlated to BRAF mutation and associated with poor survival of stage III colon cancer patients. Oncotarget. 6(28). 26278–26290. 39 indexed citations
15.
Vliet, Sandra J. van, Ilona M. Vuist, Kristiaan Lenos, et al.. (2013). Human T Cell Activation Results in Extracellular Signal-regulated Kinase (ERK)-Calcineurin-dependent Exposure of Tn Antigen on the Cell Surface and Binding of the Macrophage Galactose-type Lectin (MGL)*. Journal of Biological Chemistry. 288(38). 27519–27532. 29 indexed citations
16.
Lenos, Kristiaan, Anna M. Grawenda, Kirsten Lodder, et al.. (2012). Alternate Splicing of the p53 Inhibitor HDMX Offers a Superior Prognostic Biomarker than p53 Mutation in Human Cancer. Cancer Research. 72(16). 4074–4084. 51 indexed citations
17.
Lenos, Kristiaan & Aart G. Jochemsen. (2011). Functions of MDMX in the Modulation of the p53‐Response. BioMed Research International. 2011(1). 876173–876173. 33 indexed citations
18.
Lenos, Kristiaan, Job de Lange, Amina F.A.S. Teunisse, et al.. (2011). Oncogenic functions of hMDMX in in vitro transformation of primary human fibroblasts and embryonic retinoblasts. Molecular Cancer. 10(1). 111–111. 14 indexed citations
19.
Teunisse, Amina F.A.S., Suzanne Lam, Kirsten Lodder, et al.. (2010). HDMX-L Is Expressed from a Functional p53-responsive Promoter in the First Intron of the HDMX Gene and Participates in an Autoregulatory Feedback Loop to Control p53 Activity. Journal of Biological Chemistry. 285(38). 29111–29127. 44 indexed citations
20.
Zuckerman, Valentina, Kristiaan Lenos, Grzegorz M. Popowicz, et al.. (2008). c-Abl Phosphorylates Hdmx and Regulates Its Interaction with p53. Journal of Biological Chemistry. 284(6). 4031–4039. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fumihiko Kakizaki Breakdown of academic impact, for papers by Natascha Cremers Breakdown of academic impact, for papers by Andrea Bisso Breakdown of academic impact, for papers by Martin C. Whittle Breakdown of academic impact, for papers by Brunella Costanza Breakdown of academic impact, for papers by Lorena Alonso‐Alconada Breakdown of academic impact, for papers by Marie P. Khoury Breakdown of academic impact, for papers by Nikia A. Laurie Breakdown of academic impact, for papers by Federica Guffanti Breakdown of academic impact, for papers by Roza Zandi
Rankless by CCL
2026